Rigel Pharmaceuticals
RIGL
$1.10
Share price
0.00%
Change (1 day)
-1.79%
Change (1 year)
Categories
Rigel Pharmaceuticals (RIGL) - P/B ratio
P/B ratio as of April 2024 : -6.74
According to Rigel Pharmaceuticals's latest financial reports the company has a price-to-book ratio of -6.74.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Rigel Pharmaceuticals - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -8.83 | -53.64% |
| 2022-12-31 | -19.0 | -227.62% |
| 2021-12-31 | 14.9 | -14.17% |
| 2020-12-31 | 17.4 | 160.2% |
| 2019-12-31 | 6.68 | 90.9% |
| 2018-12-31 | 3.50 | -38.04% |
| 2017-12-31 | 5.65 | 31.97% |
| 2016-12-31 | 4.28 | 42.52% |
| 2015-12-31 | 3.00 | 92.68% |
| 2014-12-31 | 1.56 | 30.1% |
| 2013-12-31 | 1.20 | -38.86% |
| 2012-12-31 | 1.96 | -17.69% |
| 2011-12-31 | 2.38 | 0.47% |
| 2010-12-31 | 2.37 | -47.32% |
| 2009-12-31 | 4.50 | 60.06% |
| 2008-12-31 | 2.81 | -71.02% |
| 2007-12-31 | 9.70 | 182.95% |
| 2006-12-31 | 3.43 | 79.36% |
| 2005-12-31 | 1.91 | -79.19% |
| 2004-12-31 | 9.18 | 28.89% |
| 2003-12-31 | 7.12 | 260.12% |
| 2002-12-31 | 1.98 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | 23.2 | -444.96% | 🇺🇸 USA |
 AstraZeneca AZN | 5.95 | -188.34% | 🇬🇧 UK |
 Sangamo Therapeutics
SGMO | 1.30 | -119.35% | 🇺🇸 USA |